Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-28 4:35 pm Purchase |
2022-01-20 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 2,326,710 16.900% |
878,690 (+60.68%) |
Filing History |
| 2022-01-24 5:23 pm Purchase |
2022-01-13 | 13G | Aclaris Therapeutics, Inc. ACRS |
BIOTECHNOLOGY VALUE FUND L P | 3,868,043 6.300% |
3,868,043 (New Position) |
Filing History |
| 2022-01-18 5:18 pm Purchase |
2022-01-07 | 13G | Sutro Biopharma, Inc. STRO |
BIOTECHNOLOGY VALUE FUND L P | 3,160,416 6.800% |
1,306,254 (+70.45%) |
Filing History |
| 2022-01-12 5:05 pm Purchase |
2022-01-10 | 13G | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 4,526,282 14.100% |
1,425,000 (+45.95%) |
Filing History |
| 2022-01-12 5:03 pm Purchase |
2021-12-31 | 13G | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 3,101,282 9.700% |
602,381 (+24.11%) |
Filing History |
| 2022-01-11 5:13 pm Purchase |
2022-01-07 | 13D | Rain Enhancement Technologies Holdco Inc RAIN |
BIOTECHNOLOGY VALUE FUND L P | 3,526,729 18.800% |
580,922 (+19.72%) |
Filing History |
| 2022-01-10 5:57 pm Purchase |
2022-01-06 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 1,448,020 10.100% |
13,088 (+0.91%) |
Filing History |
| 2022-01-10 5:51 pm Purchase |
2021-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 1,434,932 9.990% |
1,434,932 (New Position) |
Filing History |
| 2022-01-10 4:52 pm Purchase |
2022-01-06 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 1,542,180 10.200% |
120,333 (+8.46%) |
Filing History |
| 2022-01-10 4:49 pm Purchase |
2021-12-31 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 1,421,847 9.400% |
490,097 (+52.60%) |
Filing History |
| 2022-01-03 4:34 pm Purchase |
2021-12-21 | 13G | CytomX Therapeutics, Inc. CTMX |
BIOTECHNOLOGY VALUE FUND L P | 5,803,700 8.900% |
2,884,229 (+98.79%) |
Filing History |
| 2021-12-20 5:23 pm Purchase |
2021-12-10 | 13G | Pyxis Oncology, Inc. PYXS |
BIOTECHNOLOGY VALUE FUND L P | 1,791,351 5.500% |
1,791,351 (New Position) |
Filing History |
| 2021-12-20 4:52 pm Purchase |
2021-12-16 | 13G | Cullinan Oncology, Inc. CGEM |
BIOTECHNOLOGY VALUE FUND L P | 4,394,459 10.100% |
1,787,653 (+68.58%) |
Filing History |
| 2021-12-20 4:51 pm Purchase |
2021-12-09 | 13G | Relmada Therapeutics, Inc. RLMD |
BIOTECHNOLOGY VALUE FUND L P | 1,647,400 5.900% |
1,647,400 (New Position) |
Filing History |
| 2021-12-16 5:16 pm Purchase |
2021-12-14 | 13G | Cidara Therapeutics, Inc. CDTX |
BIOTECHNOLOGY VALUE FUND L P | 343,056 10.300% |
119,982 (+53.79%) |
Filing History |
| 2021-12-02 5:05 pm Purchase |
2021-11-30 | 13D | Olema Pharmaceuticals, Inc. OLMA |
BIOTECHNOLOGY VALUE FUND L P | 7,411,503 18.400% |
750,000 (+11.26%) |
Filing History |
| 2021-11-15 4:58 pm Purchase |
2021-11-03 | 13G | Concert Pharmaceuticals, Inc. CNCE |
BIOTECHNOLOGY VALUE FUND L P | 3,596,757 9.990% |
3,596,757 (New Position) |
Filing History |
| 2021-11-08 5:20 pm Purchase |
2021-10-28 | 13G | Cullinan Oncology, Inc. CGEM |
BIOTECHNOLOGY VALUE FUND L P | 2,606,806 6.000% |
2,606,806 (New Position) |
Filing History |
| 2021-10-29 4:29 pm Purchase |
2021-10-21 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
BIOTECHNOLOGY VALUE FUND L P | 3,003,879 6.500% |
3,003,879 (New Position) |
Filing History |
| 2021-09-15 5:17 pm Purchase |
2021-08-16 | 13G | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 2,498,901 7.700% |
2,498,901 (New Position) |
Filing History |